| Patents for A61P 31 - Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics (179,784) |
|---|
| 03/11/2008 | CA2331764C Polyketides and their synthesis |
| 03/11/2008 | CA2317107C Liposomes containing multiple branch peptide constructions for use against human immunodeficiency virus |
| 03/11/2008 | CA2288147C Anti-viral pyrimidine nucleoside analogues |
| 03/11/2008 | CA2235177C New exocellular polysaccharide produced by streptococcus thermophilus |
| 03/11/2008 | CA2108135C Method and composition for the treatment of herpes related disorders |
| 03/08/2008 | CA2601358A1 Method for inducing mucosal humoral and cell-mediated immune responses by sublingual administration of antigens |
| 03/06/2008 | WO2008027466A1 Hydantoin derivatives useful as antibacterial agents |
| 03/06/2008 | WO2008027000A2 Novel drug target of preventing and treating periodontal disease, improving healing of periodontal wounds and promoting oral health |
| 03/06/2008 | WO2008026999A2 Candidates against infection |
| 03/06/2008 | WO2008026915A2 A pharmaceutical composition for the treatment of a fungal skin disorder and a method for the preparation thereof |
| 03/06/2008 | WO2008026776A1 Transdermal composition, transdermal pharmaceutical composition and transdermal cosmetic composition comprising polymer micelle encapsulating active ingredient |
| 03/06/2008 | WO2008026704A1 Isoquinoline derivative |
| 03/06/2008 | WO2008026591A1 Bactericidal agent against pathogenic bacterium of periodontal disease comprising red longhorn beetle frass as active ingredient |
| 03/06/2008 | WO2008026556A1 Freeze-dried preparation of 1-methylcarbapenem |
| 03/06/2008 | WO2008026381A1 Nail patch |
| 03/06/2008 | WO2008026172A1 Spiro antibiotic derivatives |
| 03/06/2008 | WO2008025848A2 Composition for eliciting a specific ctl response, comprising a lympho-ablative compound and a molecule that contains antigenic sequences and targets professional antigen presenting cells |
| 03/06/2008 | WO2008025847A2 Use of c7 sugars in prevention and treatment of mycoses |
| 03/06/2008 | WO2008025543A1 Pharmaceutical compositions for the treatment of fungal infections |
| 03/06/2008 | WO2008025534A1 Preparation and purification of mupirocin calcium |
| 03/06/2008 | WO2008025449A1 Treating mycobacterial infections with cyclipostins |
| 03/06/2008 | WO2008025228A1 The antibiotics composition comprising beta-lactam antibiotics and buffers |
| 03/06/2008 | WO2008025227A1 The antibiotics composition comprising aminoglycoside antibiotics |
| 03/06/2008 | WO2008025226A1 The antibiotics composition comprising beta-lactam antibiotics and ionic chelating agents |
| 03/06/2008 | WO2008025171A1 Vaccines and methods for treatment or prevention of salmonella spp. bacterial infection in a vertebrate subject |
| 03/06/2008 | WO2008025152A1 Antibacterial agents |
| 03/06/2008 | WO2008025095A1 Method of eliciting or inducing an immune response |
| 03/06/2008 | WO2008025069A1 Methods of modulating cellular activity and compositions therefor |
| 03/06/2008 | WO2008008595A3 Use of a chewing gum in a method of reducing infection |
| 03/06/2008 | WO2008008432A3 Substituted chiral fused( 1,2) imidazo (4,5-c) ring compounds and methods |
| 03/06/2008 | WO2007141392A3 Compositions comprising betulonic acid |
| 03/06/2008 | WO2007129274A3 Combination of alovudine and zidovudine in a molar ratio of 1:100 to 1:350. |
| 03/06/2008 | WO2007112518A8 Live attenuated salmonella vaccine |
| 03/06/2008 | WO2007112028A3 2'-fluoronucleoside phosphonates as antiviral agents |
| 03/06/2008 | WO2007100643A3 Methods of using antibodies against human il-22 |
| 03/06/2008 | WO2007098361A3 Laminate structure suitable for furniture exteriors |
| 03/06/2008 | WO2006117586A8 Antibody or a fragment thereof, having neutralizing activity against hiv but not against il2 |
| 03/06/2008 | US20080058733 Antibiotic(s)-polymer combination |
| 03/06/2008 | US20080058413 ester derivatives capable of reverting to the active parent compound following enzymatic or chemical hydrolysis; higher lipophilicity, lipid solubility and less irritation to the skin than the parent compound; epidermoid carcinoma and tumors induced by human papillomavirus (HPV) |
| 03/06/2008 | US20080058409 Esterified Catechins, Processes for Producing the Same, and Foods and Beverages as well as Cosmetics Containing Such Esterified Catechins |
| 03/06/2008 | US20080058372 2,5-bis{[alkyl(or aryl)imino]aminophenyl}furans and thiophenes; "reversed" amidines; DNA-binding affinities; microbiocide; mycobacterial, fungal, protozoal infection; Mycobacterium tuberculosis, Trypanosoma spp., Candida albicans, Aspergillus spp., Cryptosporidium parvum, Giardia lamblia, Plasmodium spp. |
| 03/06/2008 | US20080058371 Bactericides; produces little or no tissue damage or irritation at the injection site |
| 03/06/2008 | US20080058340 MEK kinase (mitogen-activated ERK-activating kinases or MAP kinase kinase); cancer, tumors, infections, autoimmune disorders, stroke, ischemia, rheumatoid arthritis, multiple sclerosis, psoriasis, restenosis; 1-sulfonamido-2-(phenylamino)-4-fluorobenzene compounds |
| 03/06/2008 | US20080058325 Compounds, methods and pharmaceutical compositions for inhibiting parp |
| 03/06/2008 | US20080058315 Integrase inhibitors |
| 03/06/2008 | US20080058304 Inhibitors of UPD-3-O (R-3-hydroxymyristoyl)-N-acetylglucosamine deacetylase, an enzyme present in gram negative bacteria; azetidine, pyrrolidine, or 3-pyrroline 2-carboxylic acid hydroxyamides; 1-(3,4-dimethoxy-5-propylbenzoyl)pyrrolidine-2R-carboxylic acid hydroxyamide for example |
| 03/06/2008 | US20080058296 Formulations and methods for treating rhinosinusitis |
| 03/06/2008 | US20080058270 Apolipoprotein A-I agonists and their use to treat dyslipidemic disorders |
| 03/06/2008 | US20080058251 Substituted nonadepsipeptides |
| 03/06/2008 | US20080058249 Complexes |
| 03/06/2008 | US20080057537 Nucleic acid encoding polypeptide involved in cellular entrance of the PRRS virus |
| 03/06/2008 | US20080057515 Beta-like glycoprotein hormone polypeptide and heterodimer |
| 03/06/2008 | US20080057113 virion vaccine anti-herpes simplex viruses containing hi-tech immunomodulator Polyoxidonium ( copolymer of 1,4-ethylene-piperazine N-oxide and (N-carboxyethyl)-1,4-ethylene-piperasinium bromide), valine, lysine together with metabolic amino acids; immunocompetent |
| 03/06/2008 | US20080057111 Herbal composition for flu prevention and treatment |
| 03/06/2008 | US20080057109 Bifidobacterium longum infantis strain secretes a factor that antagonizes the activity ofpro-inflammatory cytokine selected from TNF- alpha, IL-8, IFN gamma to treat inflammatory bowel disease or irritable bowel syndrome |
| 03/06/2008 | US20080057083 Protecting an animal against a pathogen by administering protective agent which is able to stimulate the animal's immune system to produce a response which is protective against the pathogen, and an immunostimulant comprising a polycationic carbohydrate or derivative thereof; non-parenteral immunization |
| 03/06/2008 | US20080057082 Attenuated rotavirus population comprising a single variant or substantially a single variant which is defined by a nucleotide sequence encoding at least one of the major viral proteins designated as VP4 and VP7; diarrhea therapy |
| 03/06/2008 | US20080057080 Polynucleotide comprising a first nucleic acid fragment which encodes at least 20 contiguous amino acids of an influenza virus polypeptide, wherein codons of nucleic acid fragment are optimized for expression in humans; enhancing immune response of vertebrate in need of protection against IV infection |
| 03/06/2008 | US20080057075 Administering an antibody derivable from normal subject or from autoimmune disease subject that binds to lipid on surface of HIV or on surface of HIV-infected cells and thereby neutralizes HIV-1; invention provides immunogens that present MPER epitopes in their native membrane bound environment |
| 03/06/2008 | US20080057074 Nitrogenous Heterocylic Derivative and Medicine Containing the Same as an Active Ingredient |
| 03/06/2008 | US20080057067 Immunogenic polypeptide fragments and vaccines; outer membrane proteins; prevention of infections including meningitis |
| 03/06/2008 | US20080057061 Targeting carbohydrates on cell or viral particle surfaces; HIV-1 infection; colon cancer, melanoma or lung cancer |
| 03/06/2008 | US20080057045 oral administration of Lactobacillus to ruminants, to prevent growth of escherichia; probiotics |
| 03/06/2008 | US20080057038 bacteriophage-drug conjugates, where the bacteriophage displays on its coat a ligand that endows it with specificity towards target cells, used as high-capacity drug delivery systems |
| 03/06/2008 | US20080057031 Antiviral phosphinate compounds |
| 03/06/2008 | CA2662219A1 Lyophilized preparation of 1-methylcarbapenem compound |
| 03/06/2008 | CA2662174A1 Vaccines and methods for treatment or prevention of salmonella spp. bacterial infection in a vertebrate subject |
| 03/06/2008 | CA2662164A1 Method of eliciting or inducing an immune response |
| 03/06/2008 | CA2662101A1 Candidates against infection |
| 03/06/2008 | CA2662083A1 Novel drug target of preventing and treating periodontal disease, improving healing of periodontal wounds and promoting oral health |
| 03/06/2008 | CA2661764A1 The antibiotics composition comprising beta-lactam antibiotics and buffers |
| 03/06/2008 | CA2661754A1 The antibiotics composition comprising beta-lactam antibiotics and ionic chelating agents |
| 03/06/2008 | CA2661605A1 Hydantoin derivatives useful as antibacterial agents |
| 03/06/2008 | CA2661590A1 Treating mycobacterial infections with cyclipostins |
| 03/06/2008 | CA2661494A1 Use of c7 sugars in prevention and treatment of mycoses |
| 03/06/2008 | CA2660939A1 Pharmaceutical compositions for the treatment of fungal infections |
| 03/06/2008 | CA2659493A1 Spiro antibiotic derivatives |
| 03/06/2008 | CA2649758A1 Preparation and purification of mupirocin calcium |
| 03/05/2008 | EP1894930A1 Thiazole derivative |
| 03/05/2008 | EP1894601A1 Treating mycobacterial infections with cyclipostins |
| 03/05/2008 | EP1894569A2 Tetracycline derivatives for treating cancer |
| 03/05/2008 | EP1893629A1 Antiviral compounds |
| 03/05/2008 | EP1893614A1 Inhibitor compounds |
| 03/05/2008 | EP1893574A2 Peptide deformylase (pdf) inhibitors 4 |
| 03/05/2008 | EP1893232A2 New adjuvant |
| 03/05/2008 | EP1893211A1 Use of sanglifehrin in hcv |
| 03/05/2008 | EP1893198A2 Treatment of liver diseases in which iron plays a role in pathogenesis |
| 03/05/2008 | EP1689795A4 Method of manufacture of polyacrolein |
| 03/05/2008 | EP1644382B1 Cross-linked glycopeptide-cephalosporin antibiotics |
| 03/05/2008 | EP1625129B1 Heterocyclyl-substituted dihydroquinazolines and use thereof as an antiviral agent |
| 03/05/2008 | EP1282710B1 Fish vaccine against piscirickettsia salmonis |
| 03/05/2008 | EP1233969B1 Mono- and disaccharide derivatives |
| 03/05/2008 | EP0690912B1 Recombinant avian adenovirus vector |
| 03/05/2008 | CN101137393A Improved vaccine against feline calicivirus |
| 03/05/2008 | CN101137391A Recombinant super-compound interferon and uses thereof |
| 03/05/2008 | CN101137382A Immunosuppressive agent and anti-tumor agent comprising heterocyclic compound as active ingredient |
| 03/05/2008 | CN101137362A Antifungal compositions comprising sertaconazol and hydrocortisone and/or an antibacterial quinolone compound |
| 03/05/2008 | CN101137359A Methods of treating ear infections |
| 03/05/2008 | CN101137358A Antiviral compositions and methods of use |
| 03/05/2008 | CN101137357A Antimicrobial compositions comprising esters of hydroxycarboxylic acids |